Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05438732 · ClinicalTrials.gov registry record · NA

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

A NA study of Age-related Macular Degeneration and Geographic Atrophy, sponsored by VisionCare.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
10
Study locations

NCT05438732 is a NA study of Age-related Macular Degeneration and Geographic Atrophy that is actively recruiting participants, run by VisionCare. The registered enrollment target is 125 participants, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (92% lower). The trial reports 10 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05438732, a NA study of Age-related Macular Degeneration and Geographic Atrophy, is actively recruiting participants, sponsored by VisionCare.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
10
Study locations

Study Summary

The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).

Conditions Studied

Age-related Macular Degeneration Geographic Atrophy

Interventions

  • DEVICE smaller incision, new generation implantable miniature telescope (SING-IMT)

Study Locations (10)

California

  • Loma Linda University - Loma Linda
  • Eye Physicians of Long Beach - Long Beach

Florida

  • Sarasota Retina Institute - Sarasota

Massachusetts

  • Tallman Eye Associates - Lawrence

Michigan

  • Oakland Ophthalmic Surgery - Birmingham

Nebraska

  • Vance Thompson Vision - Omaha

New Jersey

  • Atlantic Eye Physicians - Eatontown

North Carolina

  • Western Carolina Retinal Associates - Asheville

Ohio

  • Cleveland Clinic | Cole Eye Institute - Cleveland

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2022-06-16
Est. Completion 2025-12
Phase NA

Sponsor

VisionCare

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05438732

The ClinicalTrials.gov registry entry for NCT05438732 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (92% lower). The listed sponsor is VisionCare, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which smaller incision, new generation implantable miniature telescope (SING-IMT) is the first listed.

NCT05438732 reports 10 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05438732 about?

NCT05438732 is a clinical study titled "Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD". The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).

What is the current status of trial NCT05438732?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2022-06-16. Estimated completion is 2025-12.

What conditions does trial NCT05438732 study?

This clinical trial studies the following conditions: Age-related Macular Degeneration, Geographic Atrophy.

What interventions are being tested in trial NCT05438732?

The interventions under investigation include: smaller incision, new generation implantable miniature telescope (SING-IMT) (DEVICE).

Who is sponsoring clinical trial NCT05438732?

This trial is sponsored by VisionCare, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05438732 being conducted?

This trial has 10 study locations across California, Florida, Massachusetts, Michigan, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Age-related Macular Degeneration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Age-related Macular Degeneration

All registered trials for this condition

Geographic Atrophy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.